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ABSTRACT 
 
Gentamicin   have been shown to generate free radicals   .This study investigated   modulatory potential of aqueous 
extract of  Hibiscus Sabdariffa  calyx  with gentamicin in rats. Thirty   rats weighing between 150-200g were 
randomly selected into 6 groups: Group  A( control), group B  received 200mg/kg body weight of extract, group C 
received  80mg/ kg body weight of gentamicin intra peritoneally for six days while  group D, E and F  received 
200mg/kg, 400mg/kg and 600mg/kg body weight of  extract  for six days before and eight days following 
administration  of 80mg/kg  gentamicin.   Antioxidants and biochemical indices were  determined  using 
standardized methods  .  Rats  treated with extracts at 200mg/kg    elicit significant (p<0.05) decreases in total 
bilirubin (TB), conjugated bilirubin (C.BIL), urea, creatinine, Malondialdehyde (MDA) concentrations, Aspartate 
aminotransferase (AST), Alanine  aminotansferase (ALT) and Alkaline phosphatase (ALP) activities as well as 
significant( p<0.05) increases in Superoxide Dismutate (SOD) activity , levels of reduced glutathione (GSH) 
,albumin and total protein (TP).   Gentamicin treated  rats however showed  significant (p<0.05) decreases  in  GSH,  
TP, albumin   and SOD activities with elevated levels of MDA, TB,C.BIL, urea, creatinine and AST, ALT and ALP 
activities .  Furthermore , animals treated with various concentrations of   extract after  gentamicin administration  
showed significant increases (p<0.05) in  concentrations of TP, ALB, GSH  and SOD activities  with  corresponding 
decreases in TB, C.BIL,  urea, creatinine and MDA concentrations  as well  as AST,ALT and ALP activities  
compared with gentamicin  group  in a dose dependent manner. Properties exhibited by extract is antioxidative   
suggestive of   its  modulatory effects  on  gentamicin activity . 
 
Key words: Antioxidative,  Gentamicin,  Hibiscus Sabdariffa calyx,  Modulatory effect. 
Introduction 
Gentamicin is an aminoglycoside with broad 
bactericidal activity against many aerobic gram 
negative and some aerobic gram positive organisms 
[1]. It is the most commonly used aminoglycoside 
antibiotic and is indicated for moderate to severe 
bacterial infections caused by sensitive agents, 
primarily gram negative bacteria.  Like other 
aminoglycosides, gentamicin is thought to act by  
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binding to bacterial ribosomes and inhibiting protein 
synthesis and considered to have both bacteriocidal and 
bacteriostatic activities [2]. Gentamicin and other 
aminoglycosides are typically used in combination 
with a penicillin or cephalosporin for treatment of 
severe infections. Gentamicin is most commonly used 
for septicemia, bacterial endocarditis, peritonitis, 
meningitis, pelvic inflammatory disease and  
pneumonia[1].  It was first approved for use in the 
United States in 1970 and remains in wide use   
available in multiple generic parenteral  and topical 
formulations [3] . Topical formulations are also 
available for local wound, tissue and ophthalmologic 
anti-bacterial therapy [4], common side effects of 
gentamicin include dizziness, headache, confusion, 
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nausea and skin rash.  Important, dose related adverse 
effects include ototoxicity, hepatoxicity and 
nephrotoxicity which are shared by all 
aminoglycosides[5] .Despite its usefulness ,it has been 
shown that gentamicin treatment induces oxidative 
damage which can be attenuated  by addition of 
antioxidant agents as lipid peroxidation have been 
shown to increase in the course of gentamicin 
administration giving rise to  free radical generation 
which are highly toxic to tissues [6] . One of the 
exogenous sources of ROS is gentamicin which has 
been reported to  induce oxidative stress both  in vivo 
and in vitro  [7] , as they have been shown to be 
generated in small amounts during the  body s 
metabolic reactions  as they can react with and damage 
complex cellular molecules such as fats, protein  or 
DNA [8]  .The incidence of hepato-nephrotoxicity 
from  aminoglycosides has increased from 2 to 3% in 
1969 to 20% in the past decade [9] ,and despite this , 
aminoglycosides are being  continuosly  used in 
clinical practices because of their bacteriocidal efficacy 
,synergism with      β lactam agents ,low cost ,limited 
bacterial resistance and a post antibiotic effect  [9] 
.Free radicals generated as by products or intermediates 
of aerobic metabolism of drugs  or environmental 
toxins has cumulative effects resulting in oxidative 
stress to  surrounding cells and tissues as  products of 
ROS/RNS through either endogenous or exogenous 
sources which may be responsible for their tissue 
toxicity has widely  been reported[10];[11] .  Hence  
induced tissue toxicity by gentamicin through free 
radical productions and oxidative damage can be 
attenuated by antioxidants as they counteract the 
deleterious actions of these reactive oxygen species and 
protects against cellular damage[12] . Source for 
antioxidants has therefore become imperative in 
treatment involving certain orthodox chemotherapeutic 
agents as most of them exerts their toxic effects 
majorly by production of ROS and free radicals in their 
mode of action hence usage of some of these 
antioxidant are sourced from natural sources especially 
of plant origin.However the use of medicinal plants has 
been a central of health care in many culture  for  
centuries .More pharmaceutical drugs in the market 
contain extract from medicinal plants [13] .World 
health organisation ( WHO),estimates that up to 
80percent of the world now rely on medicinal plants as 
their source of therapeutics [2],  hence the justification 
for this study which made an attempt to  see if certain 
extract of Hibiscus sabdariffa callyx consumed locally 
and  generally as tea, or local soft drink  and beverages 
in  many areas of West Africa especially in  South 
West Nigeria may have positive effects on gentamicin  
activity .Hibiscus Sabdariffa (of the Malvaceae family) 
is a plant where its leaves and stems are commonly 
referred to as hibiscus tea and sometimes it is referred 
to as the colloquial name of roselle or Sour Tea [14] . 
The calyx (flowers) of the plants are commonly used 
for teas while the white calyx of hibiscus sabdariffa 
has the name ‘Isakpa’ by the yoruba’s of southwestern 
Nigeria, ‘krachiap daeng’ in Thailand, ‘flor de 
jamaica’ in mexico and Lo-Shen. It has limited 
traditional medicinal use and tends to be a treatment for 
high blood pressure, gastrointestinal disorders, 
purgative and diuretic diaphoresis and anuria   among 
others [15] . The red flowers have sometimes been 
used traditionally for their pigmentation as a dye which 
may have a role in histological   studies . The roselle 
(Hibiscus sabdariffa) is a species of hibiscus native to 
West Africa [16] . It is an annual or perennial herb or 
woody-based sub shrubs, growing to 2-2.5m (7-8ft) 
tall. The leaves are deeply three- five-lobed, 8-15cm 
long.Hibiscus sabdariffa (Roselle or Sour Tea) is a tea 
where the usually dark colored flowers are used to 
brew, it appears to inhibit carbohydrate absorption to a 
degree and appears to be effective in reducing blood 
pressure , it is a supplemental herb that is derived from 
the plant’s calyces, which are the collection of sepals 
separating the blooming flower from the stem. The 
calyces have traditionally been steeped into tea where 
the anthocyanins (red-blue pigmentation) is steeped 
into the water and drank for medicinal purposes [17] 
.Although several researches and findings have the 
plant extracts to possess anti-hypertensive ,anti 
cancer,anticlastogenic, hypolipidemic,anti-stress 
,antiplasmodic, diuretic ,antidiarrheal and antioxidant 
activities [18] .This study was therefore designed to 
investigates the possible modulatory effects of aqueous 
extract of  Hibiscus Sabdariffa  calyx  on gentamicin  
activity in tissues using certain antioxidants, liver and 
kidney  function indices.  
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Fig 1: Dried calyx of Hibiscus sabdariffa flower (Ezeani, N.F., 2000) 
 
Materials and Methods 
 
Materials 
 
Measuring cylinders, beakers, washing brushes, test 
tubes, disposable gloves, spectrophotometer, automatic 
micropipette, refrigerator, pipettes, spatula, incubator, 
filter paper,surgical blades, electric weighing 
balance,universal bottles, funnel, petri dishes, water 
bath, detergent, wooden rat cage, permanent marker, 
hand gloves, feeding trough, needles and syringes, 
aqueous extract of hibiscus sabdariffa, mortar and 
pestle, cotton wool, commercial rat feed, centrifuge 
and water. 
Reagents 
 
Reagents used in   this study includes; Laboratory 
assay kits for total protein, aspartate aminotransferase 
(AST), alanine aminotransferase (ALT), alkaline 
phosphate (ALP), Washing buffer, Homogenising 
buffer, Ellman’s reagent, bromocresol green, biuret 
reagent, normal saline, thiobarbituric acid, Sulphanilic 
acid, Sodium nitrite, Caffeine benzoate reagent, 
Alkaline tartrate reagent, Trichloroacetic Acid (TCA), 
Tris Hcl Buffer (P
H
 7.4), carbonate buffer (pH 10.2), 
Adrenalin, GSH working standard, Phosphate buffer 
(P
H
 7.4), all  of which were of analytical grade and  
products of Sigma chemical company USA. 
Plant material and preparation of aqueous extract 
of hibiscus sabdariffa calyx. 
 
Dried calyx of Hibiscus sabdariffa was purchased at 
Igbona  market, Osogbo   identified at the Department 
of Botany, Obafemi Awolowo University, Ile-Ife 
thereafter authenticated at the department of 
pharmacognosy Obafemi Awolowo University, Ile-Ife, 
Nigeria with herbarium voucher  number 16750  
issued. The dried calyx was   powdered  and  used for 
the extraction.The extraction of the red pigment from 
the calyx of Hibiscus sabdariffa was performed by the 
method described by [19]  . Hundred grams (100g) of 
dried Hibiscus sabdariffa  calyx was added to 500ml of 
distilled water and boiled for 15minutes. The boiled 
material was then filtered after cooling. The filtrate was 
evaporated to dryness and was stored in a sealed bottle 
at 4
0
C until required. 
 
Experimental animals and groupings 
 
Thirty wistar rats weighing between 150g-200g were 
obtained from a breeding stock in the animal House of 
the College of Health Sciences, Ladoke Akintola 
University of Technology, Osogbo. The animals were 
housed in well ventilated metal cages in the animal 
facility of the Department of Biomedical Science . The 
rats were maintained under hygienic conditions and 
were allowed to acclimatize for a period of two weeks 
with free access to rat feed and water before the 
commencement of the experiment. The animals were 
treated and handled based on the  general rules and 
guidelines for handling of laboratory animals as 
obtained in my institution and  were randomly divided 
into 6 groups (A-F)  . The dried  extract was dissolved 
in distilled water and administered orally at different 
concentrations ( 200,400 and 600 mg/kg body weight) 
while gentamicin (80mg/kg) was administered 
intraperitoneally  as shown in the table1. 
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Table 1 : Protocol table for various groups and treatments 
 
GROUPS Treatments 
A  Negative group (Feed and water only) 
B  200mg/kg b.w of extract only. 
C  Positive group (80mg/kg. b. w gentamicin only) 
D   80mg /kg. b .w gentamicin+200 mg/kg b .w of 
extract 
E   80mg/kg b.w gentamicin+400mg/kg b.w of extract 
F  80mg/kg  b.w gentamicin+600mg/kg b.w of extract 
 
  
Animal sacrifice, sample collection and preparation 
of tissue homogenates. 
The experimental animals were sacrificed 12 hours 
after the last treatment by cervical dislocation. The 
animals were carefully cut open and blood drained 
from the heart using a syringe and needle (heart 
puncturing), which was then collected into lithium 
heparin bottles. Liver   and   kidneys  were removed 
and dissected free from the fat and connective tissues. 
They were   washed using   washing buffer (1.15% 
KCl, pH 7.4) to remove haemoglobin which may 
inhibit  enzyme activity. They were   then sectioned 
and homogenized with mortar and pestle in 4ml of cold 
Trisbuffer (0.06M Tris, 1.12%KCl). The homogenates 
were centrifuged at 5000rpm for 10 min.  The resulting  
supernatant were used for the determination of MDA, 
GSH and the activities of SOD. 
 
Methods 
Biochemical analysis 
The activities of plasma ALT, AST were estimated 
using the method described by [20] ,  while 
determination of plasma activities of alkaline 
phosphatase (ALP) was estimated as described by  
[21]. Estimation of plasma bilirubin was done using 
Jendrassik and Grof method as described by [22] . 
Biuret method was used for the estimation of plasma 
total protein as described by [23],   while plasma 
albumin estimation was  carried out  using bromocresol 
green binding method as described by [24] .Also 
plasma urea concentrations were determined according 
to the method of   Berthelot-Searcy as described by 
[25] ,  while creatinine was determined by the method 
described by  [26 ]. 
Antioxidant parameters and marker of lipid 
peroxidation 
Lipid peroxidation in liver and kidney were   estimated 
spectrophotometrically by thio barbitturic acid-reacting 
substances (TBARS) as described by the procedure of 
[27]  .  Determination of GSH concentration was done 
using the method described by [28], while SOD 
activity was determined by the method of [29]. 
 
Statistical Analysis 
The SPSS (Statistical package for social sciences) 
software version 16.0 was used for the statistical 
analysis. Data obtained was analysed using analysis of 
variance (ANOVA), value of p˂0.05 was considered 
statistically significant. 
 
Results 
 
Table 2:  Plasma   total protein (TP) and albumin ( ALB) concentrations in various treatment groups  
 
Treatment groups Total Protein  ±   SD( g/l) Albumin ±   SD (g/l) 
Group A (control ) 81.97  ±  3.10 36.55    ±   3.54 
Group B(200mg/kg of extract only 82.50  ±   4.12 38.92    ±    3.53 
Group C (80mg/kg Gentamicin 
only. 
33.45   ±   3.23 12.19    ±     1.88 
GroupD(80mg/kg 
gentamicin+200mg/kg extract 
40.39    ±   3.80 14.64    ±     1.73 
Group E (80mg/kg gentamicin 
+400mg/kg extract 
54.89 
 
    ±   3.72 21.67     ±     1.61 
Group F(80mg/kg gentamicin + 
600 mg/kg extract 
67.27
 
     ±    1.68 25.71
 
     ±      1.55   
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Values were given as mean ± Standard deviation of five determinations with p value <0.05 considered statistically 
significant. 
*P-value <0.05 Considered significant when compared with Gentamicin  only  group. 
 
 
Table 3: Plasma total bilirubin (T.BIL) and conjugated bilirubin (C.BIL) concentrations in   various 
treatment group 
 
Treatment groups T.BIL(µmol/L)   C.BIL(µmol/L) ±SD 
Group A (control ) 11.25±3.57 3.55±1.05 
Group B(200mg/kg of extract only 11.09±3.74 3.29±1.55 
Group C (80mg/kg Gentamicin 
only. 
33.40±4.15 14.95±4.28 
GroupD(80mg/kg 
gentamicin+200mg/kg extract 
24.93±3.16 10.71±1.40 
Group E (80mg/kg gentamicin 
+400mg/kg extract 
24.92
 
±5.03 6.98
 
±1.19 
Group F(80mg/kg gentamicin + 
600 mg/kg extract 
17.96
 
±4.52 5.48
 
±0.96 
 
Values were given as mean ± Standard deviation of five determinations with p value <0.05 considered statistically 
significant. 
*P-value <0.05 Considered significant when compared with gentamicin only group. 
 
 
Table 4:  Plasma Aspartate aminotransferase (AST), Alanine aminotransferase (ALT) and Alkaline 
phosphatase  (ALP )activities in various treatment groups 
 
Treatment Groups AST ±SD (U/L) ALT±SD (U/L) ALP ± SD (U/L) 
Group A     (control ) 22.57±3.13 21.15±2.24 53.91±4.01 
Group B  (200mg/kg of extract only 25.55±4.88 21.52±2.74 53.21±3.48 
Group C (80mg/kg Gentamicin only. 116.75±3.75 116.86±2.89 99.28±1.95 
Group D (80mg/kg 
gentamicin+200mg/kg extract 
108.88±1.43 100.98±6..58 93.99±0.77 
Group E (80mg/kg gentamicin 
+400mg/kg extract 
100.10±1.37 91.29
 
±2.79 89.44±2.31 
Group F (80mg/kg gentamicin + 600 
mg/kg extract 
89.05
 
±0.67 82.39
 
±1.80 81.45
 
±074 
 
Values were given as mean ± Standard deviation of five determinations with p value <0.05 considered statistically 
significant. 
*P-value <0.05 Considered significant when compared with Gentamicin only group. 
 
Table 5:    Malondialdehyde (MDA), Reduced glutathione (GSH) concentrations and Superoxide dismutase 
activities (SOD) in the liver homogenates of   different treatment group 
 
Treatment Groups  MDA± SD 
(µg/mg) 
GSH ±SD  
(µmol/mg) 
 SOD±SD (U/mg)  
(µmol/mg) 
Group A     (control 33.12±2.09 6.86±1.11 25.81±2.11 
Group B  (200mg/kg of extract only 31.54±1.54 7.17
 
±1.32 27.23
 
±1.33 
Group C (80mg/kg Gentamicin only. 71.00±1.20 1.06±0.58 16.43±2.68 
Group D (80mg/kg gentamicin+200mg/kg 
extract 
68.60±1.24 1.99±0.21 17.96±2.41 
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Group E (80mg/kg gentamicin +400mg/kg 
extract 
64.74±1.91 2.26±0.60 21.78±1.35 
Group F (80mg/kg gentamicin + 600 mg/kg 
extract 
53.19
 
±2.25 5.99
 
±0.79 27.74
 
±2.24 
 
Values were given as mean ± Standard deviation of five determinations with p value <0.05 considered statistically 
significant. 
*P-value <0.05 Considered significant when compared with Gentamicin only group. 
 
 
Table 6: Plasma total protein  ,Urea and Creatinine concentrations in various treatment groups 
 
Treatment Groups Plasma Protein 
concentration 
(g/l) 
Plasma Urea 
Concentration(mmol/l) 
Plasma Creatinine 
Concentration 
(µmol/L) 
Group A     (control 81.97  ±  3.10 5.89±0.36 130.60±2.10 
Group B  (200mg/kg of 
extract only 
82.50  ±   4.12 6.11
 
±0.74 127.10±2.10 
Group C (80mg/kg 
Gentamicin only. 
33.45   ±   3.23 52.27±9.86 692.10±120.70 
Group D (80mg/kg 
gentamicin+200mg/kg 
extract 
40.39    ±   3.80 40.19±5.40 455.70±28.00 
Group E (80mg/kg 
gentamicin +400mg/kg 
extract 
54.89 
 
    ±   3.72 36.35±6.35 396.80±27.00 
Group F (80mg/kg 
gentamicin + 600 mg/kg 
extract 
67.27
 
     ±    1.68 34.62
 
±6.95 376.90
 
±59.00 
 
Values were given as mean ± Standard deviation of five determinations with p value <0.05 considered statistically 
significant.*P-value <0.05 Considered significant when compared with Gentamicin only   group. 
 
Table 7: Superoxide dismutase activity(SOD) ,Reduced glutathione (GSH) and Malondialdehyde (MDA) 
Concentrations in  the kidney homogenate of various treatment groups 
 
Treatment Groups SOD Activity 
(U/mgProtein)  
±SD 
GSH  
Concentration(µmol/mg 
protein )±SD 
MDA Concentration 
(µg/mg protein)±SD 
Group A     (control 5.39±0.41 5.78±0.44 8.88±1.23 
Group B  (200mg/kg of 
extract only 
5.85±0.29 6.78
 
±0.77 8.39
 
±0.89 
Group C (80mg/kg 
Gentamicin only. 
4.11±0.58 4.00±0.50 26.61±3.62 
Group D (80mg/kg 
gentamicin+200mg/kg 
extract 
5.44±1.14 5.51±0.74 19.04±1.43 
Group E (80mg/kg 
gentamicin +400mg/kg 
extract 
6.18±1.02 5.97±0.89 14.59±3.28 
Group F (80mg/kg 
gentamicin + 600 mg/kg 
extract 
6.94
 
±0.78 7.27
 
±0.93 13.41
 
±0.48 
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Values were given as mean ± Standard deviation of five determinations with p value <0.05 considered statistically 
significant. 
*P-value <0.05 Considered significant when compared with Gentamicin only  group. 
 
Discussion 
 
Aminoglycoside antibiotics have long been used in 
antibacterial therapy, one of which include gentamicin. 
Gentamicin is   effective against most of the life 
threatening Gram negative bacterial infections with 
reported incidence of hepato-nephrotoxicity [9]. The 
incidence of hepato-nephrotoxicity  associated with  
aminoglycosides has increased in clinical practice   
despite their  bactericidal efficacy  such that efforts are 
made through intakes of  other drugs or supplements to 
ameliorates this effects. The liver is the major site of 
synthesis of protein which includes albumin and all 
other proteins in the blood. Albumin is an important 
blood protein that is made only by the liver and 
excreted by the kidneys [30]. In this study, 
Administration of gentamicin (80mg/kg for 6 days) 
resulted in a significant (p<0.05)   decreases in plasma 
total protein and albumin concentrations ( group C) 
(33.45±3.23g/l; 12.19±1.88g/l)  compared with the  
controls (81.97±3.10g/l; 36.55±3.54g/l). However, 
treatment with different doses (200mg/kg, 400mg/kg 
and  600mg/kg) of the extract showed modulatory 
effects as it causes a dose dependent increases in  
plasma total protein and albumin levels ( table 2). The 
observed decrease in albumin could be a result of a 
decline in the number of cells responsible for albumin 
synthesis in the liver through necrosis and the direct 
interference with the albumin-synthesizing mechanism 
in the liver as   may also be implicated for decrease in 
albumin.Bilirubin is a waste product of the normal 
breakdown of red blood  cells, it passes through the 
blood into the liver where it is being conjugated to 
form a less toxic form which is eventually excreted 
through the kidney. Total Bilirubin and Conjugated 
bilirubin level were found to be significantly increased 
(p<0.05) in gentamicin   treated rats ( table 3). The 
mean total bilirubin and conjugated bilirubin in  this 
group were  (33.40±4.15µmol/L; 14.95±4.28µmol/L) ,  
compared with the  healthy controls 
(11.25±3.57µmol/L; 3.55±1.05µmol/L). However, a 
significant dose dependent reduction was observed in 
the rats treated with Hibiscus sabdariffa extract 
(200mg/kg, 400mg/kg and 600mg/kg with gentamicin )   
This improvement is attributed to the hepatoprotective 
effect of   the extract. Accumulation of bilirubin is a 
measure of alterations in binding, conjugation and 
excretory capacity of hepatocytes. The elevated level 
of bilirubin is usually an indication of biliary 
obstruction, hemolysis, and in some cases renal failure 
[31]  . The observation of increased level of plasma 
bilirubin in  gentamicin treated rats   are suggestive of   
hepatic damage which was modulated with the 
administration of the  extracts as shown in the 
results.Liver transaminases, ALT and AST are 
enzymes produced by the  hepatocytes, the working 
unit of the liver. The level of these enzymes in the 
blood is increased in conditions in which   the 
hepatocytes are damaged. Aspartate  amino 
transaminase (AST), and Alanine amino transaminase 
(ALT) , still  remained the gold standards for the 
assessment of liver injury, and have been used as 
biomarkers of choice for decades  [32] . In this study, 
there were   significant (p<0.05) increases in AST and 
ALT activities in the gentamicin treated group 
(116.75±3.73U/L; 116.86±2.89U/L) ,compared with 
the  controls (Group A) (22.57±3.13U/L; 21.15±2.24 
U/L) , which were in  agreement with several  studies 
on these  enzymes response to toxins or infectious 
agents as they are highly expressed in the blood  with 
the presence of these agents  [33] . However, a dose 
dependent reduction in the activity of these  enzymes  
were  observed   in groups ( D,E and  F) treated with 
different doses (200mg/kg, 400mg/kg and 600mg/kg) 
of the extract with gentamicin . These   activities may 
eventually  be reduced to the  controls with increased 
dosage of the extract  suggestive of the modulatory 
effects of the extract and  its   protective ability as a 
factor to decrease liver damage.Alkaline phosphatase 
(ALP),  is an enzyme found in several tissues 
throughout the body including liver, bone, kidney, 
bowel (intestine), and in the placenta. Alkaline 
phosphatase (ALP) test is often used to detect liver 
damage (blocked bile ducts) because ALP is especially 
high in the edges of cells that join to form bile ducts. In 
this study, the results showed a remarkable elevation in 
the plasma activities of ALP   following   gentamicin  
administration  ( group C) (99.28±1.95U/L) compared 
to  rats in group A (53.91±4.01U/L). The significant 
increase in plasma activities of this enzyme could be 
attributed to the damaged structural integrity of the  
liver by gentamicin. However, groups treated with the 
extract    (D, E and F) showed   a dose dependant 
decrease (93.99±0.77U/L; 89.44±2.31U/L; 
81.45±0.74U/L respectively) in plasma activities of 
this enzyme  ( table 4). In this study ,the elevated levels 
of these marker enzymes in the plasma is suggestive of 
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oxidative stress induced by ROS production by 
gentamicin and possible antioxidative effects of the 
extract in reversing this trends.  Malondialdehyde 
(MDA) results from lipid peroxidation of 
polyunsaturated fatty acids, the degree of lipid 
peroxidation can be estimated by the amount of 
malondialdehyde in tissues [34] . In this study, MDA 
was assessed as clinical biomarkers for oxidative stress 
in gentamicin   treated  rats.  MDA level was found to 
be significantly ( p<0.05)increased  in gentamicin   
administered  rats ( Group C ) ;(71.00±1.20µg/mg)  
compared to controls  (Group A); (33.12±2.09µg/mg). 
The Increased MDA  level  with gentamicin is an 
indication of  oxidative stress while  significant dose 
dependent reduction was observed in the rats treated 
with the  extract (200mg/kg, 400mg/kg and 600mg/kg) 
as  68.60±1.24µg/mg; 64.74±1.91µg/mg and 
53.19±2.25µg/mg respectively . This improvement is 
attributed to the anti oxidant  and modulatory effect of 
the extract. Reduced glutathione (GSH)   is a key 
component of the antioxidant system which protects 
the body from free radicals at the cellular level. It is 
well established that reduced glutathione (GSH), the 
most important bio molecule protecting against 
chemically induced cytotoxicity, can participate in the 
elimination of reactive intermediates by conjugation 
and hydroperoxide reduction, or of free radicals by 
direct quenching. GSH plays a key role in the 
detoxification of gentamicin reactive toxic metabolites, 
while liver necrosis begins when GSH stores are 
markedly depleted   [35]  . The results (  table 5) 
demonstrated a significant (P<0.05) decrease in hepatic 
GSH content and increase in MDA content. There is 
reduction in GSH in group intoxicated with gentamicin 
(1.06±0.58 µmol/mg)  compared with healthy  controls 
( Group A)  (6.86±1.11 µmol/mg) and significant 
(p<0.05) increase in level of MDA 
(71.00±1.20µmol/L)  compared with control 
(33.12±2.09), these results are in agreement with some 
studies suggesting  that aminoglycoside antibiotics can 
stimulate the formation of reactive oxygen species 
(ROS) which may directly be involved in gentamicin 
induced  liver failure and membrane lipid peroxidation  
[36] , while rats treated with the extract   in group D 
(200mg/kg), E (400mg/kg) and F (600mg/kg) showed 
significant ( p<0.05) increases in level of GSH 
(1.99±0.21 µmol/mg; 2.26±0.60 µmol/mg; 5.99±0.79 
µmol/mg)) respectively and significant reduction in 
MDA (68.60±1.24µmol/L; 64.74±1.91µmol/L; 
53.19±2.25µmol/L) . Also,  significant (p<0.05) 
decrease in Superoxide dismutase (SOD) activity was 
observed in the group intoxicated with gentamicin  
(16.43±2.68) when compared with the  control( group 
A ) ;(25.81±2.11). However, dose dependent increases 
were   observed in groups treated with 200mg/kg 
(17.96±2.41), 400mg/kg (21.78±1.35) and 600mg/kg 
(27.74±2.24) of the extract.  The ability of the extract 
to increase GSH levels and boost SOD activity may not 
be unconnected with its antioxidant potential and the 
ability to boost the antioxidant status of the animals  
there by modulating the activity of gentamicin.Further 
investigation of some  kidney biochemical indices and 
antioxidant status also revealed similar results as it was 
earlier reported that the clinical usage of the drug have 
been limited due to the development of 
nephrotoxicity[37] . Also, intakes of gentamicin  
arbitrarily  without prescription   has led   to increase in 
the rate of kidney damage due to the ability of the drug 
to induce generation of superoxide ,hydroxyl  radical 
and hydrogen peroxide free radicals which have been 
associated with its mode of action [38]. The  
uncontrolled presence and generation of these radicals 
and oxidants may over power the natural antioxidant 
system leading to oxidative stress . 
Results on the renal  indices( table 6) showed slight 
decreases in creatinine concentration in group B  
treated with extract only,  compared with group A. 
Also, a significant increase (p<0.05) in creatinine level 
in gentamicin treated group (group C) were observed 
which could possibly   be  a result of accumulation of 
gentamicin in the proximal tubular cells which are 
protonated in the body and bind to negatively charged 
phosphotidyl inositol or phoshotidyl serine. This 
binding causes the inhibition of lysosomal 
phospholipidosis. This excessive phospholipid 
overload causes proximal tubular necrosis as reported 
by   [39] . However, treated groups D, E and F shows 
significant decreases (p<0.05) in creatinine level when 
compared with group C. Evidence from this study 
suggests strongly that H. sabdarifja calyx aqueous 
extract may have effect on kidney  by mechanisms 
which includes the stabilization of plasma  creatinine 
and  a modulatory effect in synergy with  gentamicin . 
Therefore, further increases in concentration of the 
extract will show nephroprotective effects  as 
creatinine level decreases significantly in a 
concentration dependent manner.Furthermore ,similar 
results were obtained for the determination of urea 
concentrations as gentamicin treated group elicit  
significant increases, (p<0.05) in urea level in group C, 
when compare with the  control (group A), which may 
be a result of gentamicin inducing lysosomal 
phospholipidosis that disrupts normal renal function 
[40], given evidenced that the renal accumulation of 
gentamicin is implicated in the induction of 
nephrotoxicity as reported by  [41] . However, treated 
groups D, E and F showed   significant decrease in urea 
level compared with group C. Also , all the  antioxidant 
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parameters examined such as  MDA,GSH 
concentrations  and SOD activities   in the kidney 
homogenates  elicit similar effects as obtained in the 
liver  (Table 7), all pointing to the side effects of the 
drug  at  the treated dosage suggestive of the ability of 
the drug to induce renal oxidative stress [42] . However 
in all the treated groups with different concentrations 
of the extract   , their   modulatory   effects on the drug 
activity were identified   as these   effects were 
ameliorated   in a concentration –dependent manner. 
 
Conclusion 
 
Properties exhibited by the extract is majorly anti-
oxidative which helps in modulating the activity of 
gentamicin  and also convered hepatoprotective and 
nephroprotective  effects by mediating potent 
antioxidant effects that helped to preserved intra 
cellular levels of biological pathways that supportively 
enhance amelioration   of toxic levels of gentamicin. 
This modulatory effects is attributable to the rich 
excellent bioactive components of the plants with 
immense dietary importance and a credence to its wide 
use as local soft drinks in most West African villages 
and cities   and this   may play an important role as 
supplements on antibiotic treatment such as  
gentamicin and other derivatives. It is therefore 
recommended that further study be carried out to 
determine the specific mechanism of modulatory- 
antioxidant activity of this plant and also   determine 
whether different forms of extract from this plant can 
perform the same function.  
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